FOAMIX PHARMACEUTICALS LTD's ticker is FOMX and the CUSIP is M46135105. A total of 83 filers reported holding FOAMIX PHARMACEUTICALS LTD in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $11,205,000 | +20.4% | 3,365,000 | +9.9% | 5.37% | +191.6% |
Q3 2019 | $9,310,000 | +67.9% | 3,062,593 | +31.4% | 1.84% | +88.8% |
Q2 2019 | $5,546,000 | -23.7% | 2,330,400 | +20.3% | 0.98% | -27.0% |
Q1 2019 | $7,266,000 | -26.3% | 1,937,724 | +12.6% | 1.34% | +0.9% |
Q3 2018 | $9,863,000 | +65.8% | 1,721,378 | +44.9% | 1.32% | +36.7% |
Q2 2018 | $5,950,000 | -2.3% | 1,187,604 | 0.0% | 0.97% | -24.1% |
Q1 2018 | $6,092,000 | -14.7% | 1,187,604 | 0.0% | 1.28% | -69.2% |
Q4 2017 | $7,138,000 | +8.3% | 1,187,604 | 0.0% | 4.14% | +97.2% |
Q3 2017 | $6,591,000 | +19.7% | 1,187,604 | +0.1% | 2.10% | +15.8% |
Q2 2017 | $5,506,000 | -6.3% | 1,186,654 | 0.0% | 1.82% | -54.7% |
Q1 2017 | $5,874,000 | -66.1% | 1,186,654 | -23.9% | 4.00% | -59.2% |
Q4 2016 | $17,316,000 | +12.2% | 1,560,000 | -6.4% | 9.82% | +4.6% |
Q3 2016 | $15,440,000 | +62.3% | 1,667,377 | +11.3% | 9.38% | +56.7% |
Q2 2016 | $9,514,000 | -2.4% | 1,498,211 | +0.3% | 5.99% | +3.4% |
Q1 2016 | $9,743,000 | -14.7% | 1,494,399 | +6.1% | 5.79% | -3.0% |
Q4 2015 | $11,424,000 | +55.9% | 1,408,597 | +40.9% | 5.97% | +67.7% |
Q3 2015 | $7,330,000 | -27.4% | 1,000,000 | +1.6% | 3.56% | -32.2% |
Q2 2015 | $10,094,000 | +25.2% | 984,734 | +13.0% | 5.25% | +22.7% |
Q1 2015 | $8,063,000 | +114.3% | 871,653 | +62.4% | 4.28% | +292.3% |
Q4 2014 | $3,762,000 | +219.6% | 536,620 | +148.6% | 1.09% | +84.3% |
Q3 2014 | $1,177,000 | – | 215,896 | – | 0.59% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 4,781,708 | $28,738,000 | 4.90% |
DSC Advisors, L.P. | 1,187,604 | $7,138,000 | 4.14% |
Opaleye Management Inc. | 960,000 | $5,769,000 | 1.85% |
DAFNA Capital Management LLC | 352,741 | $2,120,000 | 1.14% |
Vivo Capital, LLC | 855,000 | $5,139,000 | 1.10% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 382,838 | $2,301,000 | 0.81% |
SENZAR ASSET MANAGEMENT, LLC | 377,397 | $2,268,000 | 0.58% |
Sio Capital Management, LLC | 131,200 | $789,000 | 0.44% |
Perceptive Advisors | 1,117,324 | $6,715,000 | 0.22% |
Tekla Capital Management LLC | 930,398 | $5,592,000 | 0.22% |